NCT04518735View on ClinicalTrials.gov

Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)

CompletedOBSERVATIONAL

Enrollment

1,707

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions

Covid19

Interventions

OTHER

Antithrombotic Therapy (anticoagulant and/or antiplatelet) before admission for Covid19

Review of medical records during hospitalization and until day 28 post-entry to compare the clinical outcomes depending on previous antithrombotic therapy

Trial Locations (1)

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT04518735 - Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) | Biotech Hunter | Biotech Hunter